先瑞达医疗(06669.HK)手术用微导管获国家药监局注册批准

阿斯达克财经
21 Jan

先瑞达医疗-B(06669.HK) 公布,昨日(20日)收到中国国家药监局对冠状动脉微导管Vericor-S2的注册批准。

据介绍,上述产品适用于冠脉血管经皮介入手术中,针对狭窄血管病变部位,引导导丝穿通病变,为更换导丝和传输生理盐水或造影剂提供通道。(js/da)(港股报价延迟最少十五分钟。)

AASTOCKS新闻

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10